TRIUMPH-3 (NCT05882045) is a Phase 3, 80-week, randomized, double-blind, placebo-controlled trial investigating the efficacy and safety of retatrutide once weekly compared with placebo in participants with severe obesity (Class 2 or Class 3), defined as BMI 35 kg/m 2 , and established cardiovascular disease
Consider how you can make this a part of your new normal Botox can help you along this path, if you are intentional about using it to help retrain those muscles
Neither the information nor the products offered are meant to diagnose, treat, cure, or prevent any medical condition
The answer is yes, and it may even be recommended
Pillars for treating CKD The FLOW trial could lead to changes in how CKD and cardiometabolic diseases as a whole are treated
Because GLP-1RA use can cause both anti-inflammatory healing benefits and adverse nutritional depletion, the association of GLP-1RA usage with surgical complications remains under investigation